Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOVIE INC. Director's Dealing 2023

Jan 18, 2023

35090_dirs_2023-01-18_38559d7f-4927-40ab-af4f-e7416d603a0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOVIE INC. (BIVI)
CIK: 0001580149
Period of Report: 2022-11-23

Reporting Person: ROGICH SIGMUND (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-23 STOCK OPTION (RIGHT TO BUY) $6.12 A 55000 Acquired 2032-11-23 COMMON STOCK (55000) Direct

Footnotes

F1: Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan.

F2: The options vest in four equal installments over a one-year period ending November 9, 2023.